Alumis Announces Pricing of Upsized Public Offering of Common Stock
Alumis Announces Pricing of Upsized Public Offering of Common Stock GlobeNewswire January 08, 2026 SOUTH SAN FRANCISCO, Calif., Jan. 07, 2026 (GLOBE NEWSWIRE) — Alumis Inc. (Nasdaq: ALMS), a clinical-stage biopharmaceutical company developing next-generation targeted therapies for patients with immune-mediated diseases, today announced the pricing of an upsized underwritten public offering of 17,650,000 shares of […]